QQ客服 官方微博 反馈留言

	Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats.
	Chen Xingxing; Ge Wenhua; Dong Tiancheng; Hu Jie; Chen Lingzhi; Fan Xiaofang; Gong Yongsheng; Zhou Hao
刊名	Life sciences
	2019
关键词	Spironolactone Endothelial-mesenchymal transition Cardiorenal syndrome Fibrosis Adenosine A2A receptor
ISSN号	1879-0631
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2826693
专题	西安交通大学
推荐引用方式 GB/T 7714	Chen Xingxing,Ge Wenhua,Dong Tiancheng,et al. Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats.[J]. Life sciences,2019.
APA	Chen Xingxing.,Ge Wenhua.,Dong Tiancheng.,Hu Jie.,Chen Lingzhi.,...&Zhou Hao.(2019).Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats..Life sciences.
MLA	Chen Xingxing,et al."Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats.".Life sciences (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。